The global Cryptoxanthin Market is estimated to be valued at US$ 740 Million in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cryptoxanthin is a natural food colorant that is derived from various fruits and vegetables such as oranges, papaya, and peppers. It is widely used in the food and beverage industry due to its numerous advantages, such as its natural sourcing, high stability, and health benefits. Cryptoxanthin is known for its antioxidant properties and is also a precursor to vitamin A. The growing trend of clean label and natural ingredients in food products is driving the demand for cryptoxanthin as a natural food colorant.
Market Key Trends:
One key trend in the cryptoxanthin market is the increasing consumer awareness regarding the harmful effects of synthetic food colorants. Consumers are becoming more conscious about the ingredients used in food products and are demanding natural alternatives. Cryptoxanthin, being a natural food colorant, is gaining traction among consumers and food manufacturers alike. Moreover, the increasing demand for clean label and natural products is further fueling the growth of the cryptoxanthin market.
PEST Analysis:
Political: The political factor influencing the cryptoxanthin market includes government regulations and policies related to food additives and supplements. The market growth may be influenced by changes in regulations governing the use of cryptoxanthin in various countries.
Economic: The economic factor affecting the cryptoxanthin market is the purchasing power of consumers. As the market primarily targets the food and beverage industry, the growth of the market is dependent on the overall economic conditions and consumer spending patterns.
Social: The social factor impacting the cryptoxanthin market is the increasing consumer awareness about the benefits of natural food additives and supplements. The rising interest in healthy and natural products is driving the demand for cryptoxanthin in various food and beverage applications.
Technological: The technological factor shaping the cryptoxanthin market is the advancement in extraction and production techniques. Improvements in extraction methods and product formulation have enabled manufacturers to offer high-quality cryptoxanthin products, thereby driving their market growth.
Key Takeaways:
The Global Cryptoxanthin Market Size is expected to witness high growth, exhibiting a CAGR of 5.7% over the forecast period of 2023-2030. The increasing consumer demand for natural food additives and supplements is one of the key drivers for market growth. Additionally, the growing awareness about the health benefits of cryptoxanthin has resulted in its increased usage in various food and beverage applications, further fueling market growth.
In terms of regional analysis, Asia Pacific is anticipated to be the fastest-growing and dominating region in the cryptoxanthin market. The region’s large population, rising disposable income, and changing dietary patterns are driving the demand for healthy and natural food additives, including cryptoxanthin. Moreover, the increasing investments by key players in the region to expand their production capacities and distribution networks are also contributing to the market growth in Asia Pacific.
Key players operating in the cryptoxanthin market include BASF, DSM, Kemin Industries, Naturex, Synthite Industries, Aarkay Food Products, Dohler, Sensient Technologies, and Vitablend. These key players focus on product development, partnerships, and acquisitions to expand their market presence and meet the growing consumer demand for cryptoxanthin.
Read More- https://www.newsstatix.com/cryptoxanthin-market-size-share-values-and-forecast-analysis/
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
Jun 04, 2019 (AB Digital via COMTEX) -- Market Synopsis
The Global Agriculture Bactericides Market is presumed to expand at 4.7% CAGR during the forecast period (2017-2023) owing to the rising demand for food grains, asserts Market Research Future (MRFR).
With the change in climate, there has been a noticeable increase in the pest life cycle which is considered to be one of the major factors driving the Agriculture Bactericides Market both in developed and developing countries.
Moreover, the growing demand for crop protectants from bacterial infection is estimated to foster the market growth at a global level.
The major players operating the global market for agriculture bactericides are-
E. I. du Pont de Nemours and Company (U.S.)
India Color Sorter Market, By Type (Chute and Belt) By Application (Agricultural and Industrial), and Region - Forecast 2016-2022.
The color sorter market is highly application driven and is demanded by agricultural sector majorly.
The color sorter machines and systems detect the colors of seeds and grains that pass before them using devices such as cameras.
The market in India is divided on the basis of type into chute and belt and on the basis of application into agricultural and industrial.
India Color Sorter Market was valued at USD 16.5 Million in 2015 and is projected to grow at a CAGR of 2.05% during the forecast period.
To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the automotive gear market
